期刊文献+

甘草酸二钾滴眼液的研制 被引量:2

Development of Dipotassium Glycyrrhizinate Eye Drops
下载PDF
导出
摘要 目的研制用于治疗非感染性眼部炎症的甘草酸二钾滴眼液。方法优化处方、工艺,制定质量标准;建立HPLC含量测定法;进行稳定性考察和局部刺激性试验。结果含量测定的高、中、低浓度平均回收率分别为100.32%,100.18%和100.12%,RSD分别为0.38%,0.31%和0.34%;加速6个月和长期放置24个月质量稳定;对兔眼无明显刺激作用。结论研制的甘草酸二钾滴眼液处方合理,制备工艺稳定,质量可控,对兔眼无刺激,可用于临床。 Objective To prepare dipotassium glycyrrhizinate eye drops for the treatment of non-infectious ocular inflammation. Methods The formula and preparation process of the eye drops were optimized, and the quality standard was drafted. The determination of dipotassium glycyrrhizinate by HPLC was established. The stability and local irritation tests were performed. Results The average recoveries of dipotassium glycyrrhizinate eye drops with high, medium and low concentrations were 100.32 %, 100.18 % and 100.12 % with RSD of 0.38 %, 0.31% and 0.34 %, respectively. The samples were stable for 24 months in a long-term test and 6 months in an accelerated test, and had no irritation on rabbits' eyes. Condusion With a reasonable formula, stable preparation process, controllable quality and non-irritation, the dipotassium glycyrrhizinate eye drops prepared in this study can be applied in clinical trials.
出处 《食品与药品》 CAS 2008年第6期18-20,共3页 Food and Drug
关键词 甘草酸二钾 滴眼液 质量控制 dipotassium glycyrrhizinate eye drops quality control
  • 相关文献

参考文献5

二级参考文献39

  • 1晏晓明.关注滴眼剂的眼表毒性[J].中华眼科杂志,2005,41(5):387-389. 被引量:70
  • 2[1]Takeda S,Ishthara K, Wakui Y, et al. Bioavailability study ofglycyrrhetic acid after oral administration of glycyrrhizin in rats;relevance to the intestinal bacterial hydrolysis[J].J PharmPharmacol,1996, 48(9):902.
  • 3[2]Van Rossum TG, Vulto AG, De Man RA, et al. Review article:glycyrrhizinas a potential treatment for chron-ic hepatitis C[J].Aliment Pharmacol Ther, 1998, 12(2):199.
  • 4[3]Van Rossum TG, Vulto AG, Hop WC, et al.Intraveno-us glycyrrhizin for the treatment of chronic hepatitis C:a double-blind, randomized, placebo controlled pha-se I/II trial[J]. J Gastroenterol Hepatol,1999, 14(11):1 093.
  • 5[4]Yamamura Y, Kotaki H, Tanaka N, et al. The pharmaco-kinetics of glycyrrhizin and its restorative effect on he-patic function in patients with chronic hepatitis and in chronicallycarbon-tetrachloride-intoxicated rats[J].Biopharm Drug Dispos, 1997, 18(8):717.
  • 6[5]Yamamura Y, Santa T, Kotaki H, et al. Administrationroute dependency of absorption of glycyrrhizin in rat-
  • 7[6]s:intraperitoneal administration dramatically enhancedbioavailability[J]. Biol Pharm Bull, 1995,18(2):337.
  • 8[7]Okamoto T, Tanaka N, Vulto AG, et al. The protectiveeffect of glycyrrhizin on anti-fas antibody-inducedhepatitis in mice[J]. Eur J Pharmacol, 2000, 387(2):229.
  • 9[8]Okamoto T, Kanda T, Vulto AG, et al. Glycyrrhizin protects mice fromconcanavalin A-induced hepatitiswithout affecting cytokine expression[J]. Int J Mol M-ecl, 1999, 4(2):149.
  • 10[9]Tsabota A. Corrbinecl ursodeoxycholic acid and glycyrrhizin therapy forchronic hepatitis C virus infection:a randomized controlled trial in 170patients[J].Eur J Gastroenterd Hepatol, 1999, 11(10):1 077.

共引文献125

同被引文献24

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部